If you need more lookups,
subscriptions start at $34 USD/month.
Stephen Camiolo Location
Louisville, KY, US
Stephen Camiolo Work
2026 -now Head of Cell Therapy Commercialization @
2025 -2026 Senior Vice President @
2023 -2025 Vice President, Cell Therapy Account Teams @
2022 -2023 Head of Market Access Operations, Distribution and Pricing @
2021 -2022 Vice President, Market Access and Pricing @
2018 -2021 Executive Director U.S. Market Access Strategy, Pricing, National Accounts @
2014 -2021 Director Oncology GPO Marketing, Market Access @
2018 -2020 Senior Director Oncology GPO Marketing, Market Access @
2013 -2014 Associate Director Oncology Marketing @
2011 -2013 Associate Director Marketing Ischemic Heart Disease @
2010 -2011 Regional Sales Director IHD Sales @
2008 -2010 Senior Regional Account Director (Academic Medical Centers) @
2006 -2008 Associate Director Thought Leader Development @
2003 -2006 District Sales Manager @
1999 -2003 Senior Sales Consultant @
Stephen Camiolo Education
Spalding University
BSN (Nursing)
1993-1997
Stephen Camiolo Skills
Nephrology
Business Planning
Rheumatology
Pharmaceutical Sales
Urology
Oncology
Cardiology
Sales
Marketing
Managed Care
Hospitals
Dermatology
Neurology
Product Launch
Biotechnology
Gastroenterology
Hospital Sales
Endocrinology
Diabetes
Pharmaceutical Industry
Sales Effectiveness
Healthcare
Project Management
Microsoft Office
Sales Management
Stephen Camiolo Summary
Stephen Camiolo, based in Louisville, KY, US, is currently a Head of Cell Therapy Commercialization at US WorldMeds. Stephen Camiolo brings experience from previous roles at TScan Therapeutics, Iovance Biotherapeutics, Inc. and CRISPR Therapeutics. Stephen Camiolo holds a 1993 - 1997 BSN in Nursing @ Spalding University. With a robust skill set that includes Nephrology, Business Planning, Rheumatology, Pharmaceutical Sales, Urology and more. Stephen Camiolo has 1 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Stephen Camiolo?
Find contact details for 700 million professionals.